Ventricular quadrigeminy is an unusual cardiac rhythm disorder characterized by a distinctive pattern in which every fourth heartbeat is a premature ventricular contraction (PVC). Unlike the regular rhythm seen in a healthy heart, ventricular quadrigeminy introduces a disruption with these premature contractions arising from the ventricles. This unique four-beat sequence sets it apart from typical cardiac rhythms. While the immediate health risks of ventricular quadrigeminy might be limited, it can signal an underlying heart condition, prompting the need for further assessment by a healthcare professional. The use of electrocardiograms (ECGs) is pivotal in monitoring and comprehending the cardiac rhythm, allowing for the identification and management of ventricular quadrigeminy to maintain optimal heart health.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States